Oligonucleotide aptamers: new tools for targeted cancer therapy
H Sun, X Zhu, PY Lu, RR Rosato, W Tan… - Molecular Therapy-Nucleic …, 2014 - cell.com
Aptamers are a class of small nucleic acid ligands that are composed of RNA or single-
stranded DNA oligonucleotides and have high specificity and affinity for their targets. Similar …
stranded DNA oligonucleotides and have high specificity and affinity for their targets. Similar …
Current approaches in SELEX: An update to aptamer selection technology
M Darmostuk, S Rimpelova, H Gbelcova, T Ruml - Biotechnology advances, 2015 - Elsevier
Systematic evolution of ligands by exponential enrichment (SELEX) is a well-established
and efficient technology for the generation of oligonucleotides with a high target affinity …
and efficient technology for the generation of oligonucleotides with a high target affinity …
Cell-type-specific, aptamer-functionalized agents for targeted disease therapy
One hundred years ago, Dr. Paul Ehrlich popularized the" magic bullet" concept for cancer
therapy in which an ideal therapeutic agent would only kill the specific tumor cells it targeted …
therapy in which an ideal therapeutic agent would only kill the specific tumor cells it targeted …
[HTML][HTML] Modern affinity reagents: Recombinant antibodies and aptamers
K Groff, J Brown, AJ Clippinger - Biotechnology advances, 2015 - Elsevier
Affinity reagents are essential tools in both basic and applied research; however, there is a
growing concern about the reproducibility of animal-derived monoclonal antibodies. The …
growing concern about the reproducibility of animal-derived monoclonal antibodies. The …
Generation of aptamers with an expanded chemical repertoire
S Diafa, M Hollenstein - Molecules, 2015 - mdpi.com
The enzymatic co-polymerization of modified nucleoside triphosphates (dN* TPs and N*
TPs) is a versatile method for the expansion and exploration of expanded chemical space in …
TPs) is a versatile method for the expansion and exploration of expanded chemical space in …
Therapeutic Potential of Aptamer–Protein Interactions
AS Shraim, BA Abdel Majeed… - ACS Pharmacology & …, 2022 - ACS Publications
Aptamers are single-stranded oligonucleotides (RNA or DNA) with a typical length between
25 and 100 nucleotides which fold into three-dimensional structures capable of binding to …
25 and 100 nucleotides which fold into three-dimensional structures capable of binding to …
A DNA aptamer recognising a malaria protein biomarker can function as part of a DNA origami assembly
M Godonoga, TY Lin, A Oshima, K Sumitomo… - Scientific reports, 2016 - nature.com
DNA aptamers have potential for disease diagnosis and as therapeutics, particularly when
interfaced with programmable molecular technology. Here we have combined DNA …
interfaced with programmable molecular technology. Here we have combined DNA …
Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors
F Ghaedrahmati, N Esmaeil… - Cancer …, 2023 - Wiley Online Library
Natural killer (NK) cells are unique innate immune cells that mediate anti‐viral and anti‐
tumor responses. Thus, they might hold great potential for cancer immunotherapy. NK cell …
tumor responses. Thus, they might hold great potential for cancer immunotherapy. NK cell …
MIPs and aptamers for recognition of proteins in biomimetic sensing
Biomimetic binders and catalysts have been generated in order to substitute the biological
pendants in separation techniques and bioanalysis. The two major approaches use either …
pendants in separation techniques and bioanalysis. The two major approaches use either …
Selection of DNA aptamers against Human Cardiac Troponin I for colorimetric sensor based dot blot application
GS Dorraj, MJ Rassaee, AM Latifi, B Pishgoo… - Journal of …, 2015 - Elsevier
Troponin T and I are ideal markers which are highly sensitive and specific for myocardial
injury and have shown better efficacy than earlier markers. Since aptamers are ssDNA or …
injury and have shown better efficacy than earlier markers. Since aptamers are ssDNA or …